Nyxoah S.A. (NASDAQ:NYXH) shares saw strong trading volume on Monday . 1,600 shares were traded during mid-day trading, a decline of 92% from the previous session’s volume of 20,991 shares.The stock last traded at $30.05 and had previously closed at $30.66.
Several research analysts have recently commented on the company. Cantor Fitzgerald assumed coverage on Nyxoah in a report on Wednesday, July 28th. They issued an “overweight” rating and a $43.00 target price on the stock. Stifel Nicolaus started coverage on Nyxoah in a report on Tuesday, July 27th. They issued a “buy” rating and a $43.00 target price on the stock. Piper Sandler started coverage on Nyxoah in a report on Wednesday, July 28th. They set an “overweight” rating and a $40.00 price objective on the stock. Finally, Kepler Capital Markets reaffirmed a “buy” rating on shares of Nyxoah in a report on Tuesday, July 6th.
The company’s 50 day simple moving average is $31.23.
Nyxoah SA, a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea.
Featured Story: Trading Options- What is a Strangle?
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.